Logo

Balaxi Pharma. Share Price

Balaxi Pharma. (INR)72.14-2.8   (-3.8%)

Exchange ScripsBSENSEBALAXIISININE618N01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Balaxi Pharma. Performance

Market performance
Open price74.96
High75.93
Volumes29190
Prev Close72.14
Low71.5
Closing date2025-01-10
Historical performance
1 Year High151.45
3 Year High151.45
5 Year High216.04
1 Year Low68.91
3 Year Low60.71
5 Year Low12.81

Balaxi Pharma. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
398
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
107.69
Dividend Yield
Dividend Yield
N/A

Balaxi Pharma. Investment Returns

1 Year
-16.7%
3 Years
-29.8%
5 Years
401%
10 Years
N/A

Balaxi Pharma. Technicals

IndicatorsValueSignal
5-DMA77.09Bearish
10-DMA74.77Bearish
20-DMA76Bearish
50-DMA80.04Bearish
100-DMA91.81Bearish
200-DMA104.39Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters33333
Foreign Investors---------------
Domestic Investors33333
Public Investors78606583520350425044
Government---------------

Balaxi Pharma. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income6265022
Operating Profit452601558449
Interest281483
Depreciation211853
Profit Before Tax20569545443
Consolidated Net Profit-73517482372
Adjusted EPS-110107

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital109102100100
Total Reserves186716241032550
Minority Interest------------
Total Non-Current Liabilities2837------
Total Liabilities258323971765997
Capital Work in Progress23286---
Total Assets258323971765997

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities4961341---
Cash Flow from Investing Activities-10-106-284-60
Cash Flow from Financing Activitie303255-236
Net Cash Inflow / Outflow34121055-23
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 107.69.
  • 3Y Stock Price CAGR of the stock is -11.1.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹78 Million.
  • The company generated revenue of ₹702 Million in the previous financial year.

Balaxi Pharma.

72.14-2.8   (-3.8%)

Investment Amount: ₹ 8865
Current Value: ₹ 7214
Performance: -18.6%
P/L: ₹ -1651
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Orient Technologies

39.1

597.75

December 12 - January 12

Lloyds Enterprises

16.7

57.17

December 12 - January 12

Manoj Vaibhav Gems

15.7

284.8

December 12 - January 12

Future Consumer

13.8

0.66

December 12 - January 12

Kothari Products

7.2

177.46

December 12 - January 12

TVS Electronics

3.3

378.4

December 12 - January 12

ABM International

2.6

66.7

December 12 - January 12

Mittal Life Style

2.4

2.1

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month